US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: 21.7% Potential Upside Ignites Investor Interest

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, has captured the attention of investors with its compelling growth prospects and robust operational performance. As the company..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 39.35% Potential Upside Amid Robust Healthcare Innovations

Globus Medical, Inc. (NYSE: GMED) has solidified its position as a formidable player in the medical devices industry, particularly within the healthcare sector, as it continues to address the growing..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 12.59% Potential Upside in the Revolutionary Organ Transplant Space

TransMedics Group, Inc. (NASDAQ: TMDX) is at the forefront of transforming organ transplantation with its innovative Organ Care System (OCS), a technology that aims to optimize organ preservation and improve..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Challenging Market with Strategic Resilience

Integer Holdings Corporation (NYSE: ITGR), a noteworthy player in the healthcare sector, particularly within the medical devices industry, has been capturing investor attention with its strategic focus on contract development..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 31% Upside Potential in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a global leader in eye care products, offers an intriguing investment opportunity with a potential upside of 31.06%, according to analyst target price estimates. As a..

BioMarin Pharmaceutical Inc. (BMRN): Stock Analysis Reveals 43% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology company based in San Rafael, California, specializes in developing therapies for life-threatening rare diseases. With a current market capitalization of $12.38 billion,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Navigating a 63.78% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a prominent player in the biotechnology sector, focusing on innovative solutions for genetic diseases. With a market cap of $13.02 billion, the company is..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Avantor, Inc. (AVTR), a prominent player in the healthcare sector, offers investors a unique proposition with its extensive range of mission-critical products and services. Headquartered in Radnor, Pennsylvania, Avantor has..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.78% Upside with Strategic Collaborations

Viatris Inc. (VTRS) is capturing attention in the healthcare sector, offering a myriad of opportunities for investors keen on the drug manufacturing industry. As a global player, Viatris operates across..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Diagnostics Giant with a Cautious Analyst Outlook

Revvity, Inc. (RVTY), a significant player in the healthcare sector, is carving a niche in the diagnostics and research industry. Based in Waltham, Massachusetts, and boasting a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Potential 31.52% Upside in Biotech Sector

Ascendis Pharma A/S (NASDAQ: ASND), a prominent player in the biopharmaceutical industry, has been making waves with its innovative approach to addressing unmet medical needs. Based in Hellerup, Denmark, this..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Challenges of Growth in the Medical Devices Sector

For investors keen on the healthcare sector, Inspire Medical Systems, Inc. (NASDAQ: INSP) offers a compelling case study in the medical devices industry. Headquartered in Golden Valley, Minnesota, this innovative..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Poised for 36% Upside

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, is presenting an intriguing opportunity for investors. With a market capitalization of $105.53 billion, Stryker operates at the forefront..

Solventum Corporation (SOLV) Investor Outlook: Evaluating a 5.72% Upside with Robust ROE Metrics

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing attention from investors with its potential upside of 5.72% and an impressive Return on Equity (ROE) of 33.96%...

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Potential 61% Upside Amid Innovative Cardiac Solutions

iRhythm Holdings, Inc. (NASDAQ: IRTC), a standout in the healthcare sector specializing in medical devices, is capturing the attention of investors with a notable potential upside of 61.11%. The company,..

Doximity, Inc. (DOCS) Stock Analysis: Exploring the 14.69% Potential Upside for Healthcare Investors

Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry, presents a unique investment opportunity with a projected potential upside of 14.69%. With a current market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering Growth Potential Amidst Healthcare Innovation

Novo Nordisk A/S (NYSE: NVO), a prominent player in the healthcare sector, is a beacon of innovation in the drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company is renowned..

Corcept Therapeutics (CORT) Stock Analysis: A Promising Biotech with 27.84% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as a compelling player in the biotechnology sector. With a robust market capitalization of $11.92 billion, the company is making significant strides in..

The Cigna Group (CI) Investor Outlook: Analysts Signal 23% Upside Potential

The Cigna Group (NYSE: CI), a formidable player in the healthcare plans industry, stands as a compelling investment opportunity with a market capitalization of $72.74 billion. Operating primarily in the..

Insmed Incorporated (INSM) Stock Report: A Biotech Powerhouse with 66% Potential Upside

For investors with a keen interest in biotechnology, Insmed Incorporated (NASDAQ: INSM) presents a compelling opportunity. With a market cap of $26.21 billion, this U.S.-based healthcare innovator focuses on developing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds